
GERON CORP — Investor Relations & Filings
Geron Corp is a commercial-stage biopharmaceutical company focused on developing and commercializing therapies for hematologic malignancies. Its lead product, imetelstat, is a first-in-class telomerase inhibitor approved for the treatment of certain blood cancers. The company's scientific approach targets telomerase to alter the course of hematologic myeloid malignancies, with the goal of extending and enhancing the lives of patients.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 10-Q - GERON CORP (0000886744) (Filer) | 2026-05-06 | English | |
| ARS - GERON CORP (0000886744) (Filer) | 2026-04-07 | English | |
| DEF 14A - GERON CORP (0000886744) (Filer) | 2026-04-07 | English | |
| SCHEDULE 13G/A - GERON CORP (0000886744) (Subject) | 2026-03-26 | English | |
| 4 - GERON CORP (0000886744) (Issuer) | 2026-03-26 | English | |
| 3 - GERON CORP (0000886744) (Issuer) | 2026-03-26 | English |
Browse filings by year
18 yearsMarket data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Curaleaf
Cultivates, processes, and distributes medical and wellness…
|
CURA | CA | Manufacturing |
|
Curanex Pharmaceuticals Inc
Develops botanical drugs for inflammatory diseases like ulc…
|
CURX | US | Manufacturing |
|
Curasight A/S
A clinical-stage biotech developing a theranostic platform …
|
CURAS | DK | Manufacturing |
|
Curevac
A biopharmaceutical company developing therapies based on m…
|
CVAC | NL | Manufacturing |
|
CureVac N.V.
A biopharmaceutical company developing mRNA-based medicines…
|
CVAC | US | Manufacturing |
|
CURIS INC
Biotechnology company developing and commercializing therap…
|
CRIS | US | Manufacturing |
|
Curis Lifesciences Limited
Researches and produces therapeutic formulations for divers…
|
CURIS | IN | Manufacturing |
|
Curocell Inc.
A clinical-stage biotech developing CAR-T therapies for blo…
|
372320 | KR | Manufacturing |
|
Cutia Therapeutics
R&D-driven biopharma specializing in developing and commerc…
|
2487 | HK | Manufacturing |
|
Cybin Inc.
Clinical-stage biopharma developing breakthrough neuropsych…
|
HELP | CA | Manufacturing |
GERON CORP via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/32370/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=32370 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=32370 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=32370 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 32370}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for GERON CORP (id: 32370)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.